Collection of samples
Collection of samples is a biological therapy with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Comparison of the Non-invasive Approach and Fetal Exome Sequencing in Prenatal Diagnosis When Fetal Ultrasound Signs Are Discovered
Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients
An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis
Clinical Trials (5)
Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Comparison of the Non-invasive Approach and Fetal Exome Sequencing in Prenatal Diagnosis When Fetal Ultrasound Signs Are Discovered
Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients
An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5